Novavax, Inc.
NASDAQ:NVAXBiotechnology
Healthcare
$7.72 -1.84%
-$0.18 today
- Market cap
- $1.27B
- Beta
- 2.41
- P/E (TTM)
- -17.3
- EPS (TTM)
- -$0.54
52W Low $6.13High $11.97
Volume 4.34M
Average 4.58M
Price history
Novavax, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+24.12%
Period high
$12.82
Period low
$6.22
Latest
$7.72
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Oct 29, 2026 | Oct 29, 2026 | |
| SC 13D/A | Oct 16, 2026 | Oct 16, 2026 | |
| SC 13G | Oct 16, 2026 | Oct 16, 2026 | |
| SC 13G | Aug 7, 2026 | Aug 7, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Aug 6, 2026 | Aug 6, 2026 | |
| S-8 | Aug 6, 2026 | Aug 6, 2026 | |
| 4 | Jun 23, 2026 | Jun 23, 2026 | |
| 4 | Jun 23, 2026 | Jun 23, 2026 | |
| 4 | Jun 23, 2026 | Jun 23, 2026 | |
| 4 | Jun 23, 2026 | Jun 23, 2026 | |
| 4 | Jun 23, 2026 | Jun 23, 2026 |
Competitors
Who does Novavax, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about NVAX's filings, answered from its disclosures.
What is the latest NVAX filing?
The latest filing shown is SC 13G dated Nov 10, 2026.
How many recent filings does NVAX have?
Intrinsic Alpha currently shows 20 recent filings for NVAX.
Continue the stock analysis
Jump to another research area for this company.